There is increasing evidence that NGAL is not only a marker of AKI per se but also a predictor of AKI severity and AKI-related outcomes such as requirement of RRT, length of hospital stay (LOS), and mortality [15,20]. This evidence concerns the gene LCN2 and acute kidney injury.